Screener
ALX Oncology Holdings Inc. ALXO Q2 2026 earnings
Reported August 6, 2026 · Before market open
EPS-$0.13Beat by $0.01
EPS estimate-$0.14
Next report
Nov 6, 2026 (in 2 months)EPS estimate-$0.15
Versus estimates
Diluted EPS
FAQ
- When did ALX Oncology Holdings Inc. report Q2 2026 earnings?
- ALX Oncology Holdings Inc. (ALXO) reported Q2 2026 earnings on August 6, 2026 before market open.
- What were ALX Oncology Holdings Inc.'s Q2 2026 revenue and EPS?
- ALX Oncology Holdings Inc. reported eps of $-0.13 for Q2 2026.
- Did ALX Oncology Holdings Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.14 by $0.01.
- How did ALX Oncology Holdings Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 73.5% from $-0.49.
- Where can I find ALX Oncology Holdings Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-336843) and the 10-Q periodic report (0001193125-26-337920) directly on SEC EDGAR. The filing index links above go to sec.gov.
